Objective: To estimate the accuracy of frozen pathological analysis in patients preoperatively diagnosed with endometrial atypical complex hyperplasia (ACH) and to develop a model predicting the probability of the presence of endometrial carcinoma in ACH. Methods: Patients (n = 128) who underwent total hysterectomies because of diagnoses of ACH were evaluated at four tertiary centers. Results: Diagnoses made using frozen sections and permanent sections were in good agreement (ĸ = 0.61, p < 0.0001). A useful scoring system combining weighted risk factors derived from a regression model is as follows: (2 × age ≥50 years) + (3 × BMI ≥30) + (2 × menopausal status) + (2 × diabetes comorbidity) + (3 × endometrial thickness >12 mm). The AUC of this score was 0.793, and the score afforded 80.9% sensitivity, 70.3% specificity, a 75.3% positive predictive value, and a 76.4% negative predictive value, when a score of 5 was used as a cutoff. Conclusions: Patients with ACH should be evaluated by gynecological oncologists and intraoperative frozen section analysis should be performed by pathologists specializing in the evaluation of gynecological malignancies, because ACH is closely associated with endometrial cancer (EC). Our novel preoperative scoring system may aid in the detection of patients at increased risk of EC and thus guide general gynecologists.

Keywords:
Endometrial atypical complex hyperplasia, Frozen section, Endometrial carcinoma, Preoperative scoring system
1.
Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2.
Republic of Turkey Ministry of Health: Turkey Cancer Statistics. January 2014 report.
3.
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, et al: Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001;32:569-577.
4.
Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long-term study of ‘untreated' hyperplasia in 170 patients. Cancer 1985;56:403-412.
5.
Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd, et al: Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812-819.
6.
Berek J, Hacker N: Gynecologic Oncology, ed 5. Philadelphia, Lippincott Williams & Wilkins, 2010.
7.
Bilgin T, Ozuysal S, Ozan H, Atakan T: Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia. J Obstet Gynaecol Res 2004;30:205-209.
8.
Salman MC, Usubutun A, Dogan NU, Yuce K: The accuracy of frozen section at hysterectomy in patients with atypical endometrial hyperplasia. Clin Exp Obstet Gynecol 2009;36:31-34.
9.
Attard-Montalto S, Coutts M, Devaja O, Summers J, Jyothirmayi R, Papadopoulos A: Accuracy of frozen section diagnosis in pre-malignant and malignant lesions of the endometrium. Eur J Gynaecol Oncol 2008;29:435-440.
10.
Morotti M, Menada MV, Moioli M, Sala P, Maffeo I, Abete L, et al: Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Gynecol Oncol 2012;125:536-540.
11.
Turan T, Karadag B, Karabuk E, Tulunay G, Ozgul N, Gultekin M, et al: Accuracy of frozen sections for intraoperative diagnosis of complex atypical endometrial hyperplasia. Asian Pac J Cancer Prev 2012;13:1953-1956.
12.
Indermaur MD, Shoup B, Tebes S, Lancaster JM: The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative diagnosis. Am J Obstet Gynecol 2007;196:e40-e42.
13.
Tavassoéli FA, Devilee P; International Agency for Research on Cancer/World Health Organization: Tumours of the breast and female genital organs; in IARC WHO Classification of Tumours, ed 1. IARC/WHO, 2003, p 23.
14.
Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long-term study of ‘untreated' hyperplasia in 170 patients. Cancer 1985;56:403-412.
15.
Ferenczy A, Gelfand M: The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989;160:126-131.
16.
Eddib A, Allaf B, Lee J, Yeh J: Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia. Gynecol Obstet Invest 2012;73:38-42.
17.
American College of Obstetricians and Gynecologists: ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005;106:413-425.
18.
Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, et al: Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:804-811.
19.
Coffey D, Kaplan AL, Ramzy I: Intraoperative consultation in gynecologic pathology. Arch Pathol Lab Med 2005;129:1544-1557.
20.
Merisio C, Berretta R, De Ioris A, Pultrone DC, Rolla M, Giordano G, et al: Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 2005;122:107-111.
21.
Antonsen SL, Ulrich L, Høgdall C: Patients with atypical hyperplasia of the endometrium should be treated in oncological centers. Gynecol Oncol 2012;125:124-128.
22.
Dankwa EK, Davies JD: Frozen section diagnosis: an audit. J Clin Pathol 1985;38:1235-1240.
23.
Fanning J, Tsukada Y, Piver MS: Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990;37:47-50.
24.
Gredmark T, Kvint S, Havel G, Mattsson LA: Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol 1999;72:138-142.
25.
He F, Zhang W, Zhang H: Apoptotic signaling pathways in uteri of rats with endometrial hyperplasia induced by ovariectomy combined with estrogen. Gynecol Obstet Invest 2013;76:51-56.
26.
Chen YL, Cheng WF, Lin MC, Huang CY, Hsieh CY, Chen CA: Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia. J Formos Med Assoc 2009;108:502-507.
27.
Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA: Risk factors for adenomatous endometrial hyperplasia: a case-control study. Am J Epidemiol 1986;123:291-301.
28.
Armstrong AJ, Hurd WW, Elguero S, Barker NM, Zanotti KM: Diagnosis and management of endometrial hyperplasia. J Minim Invasive Gynecol 2012;19:562-571.
29.
Friberg E, Orsini N, Mantzoros CS, Wolk A: Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-1374.
30.
Smith-Bindman R, Weiss E, Feldstein V: How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol 2004;24:558-565.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.